Literature DB >> 8381850

Oral magnesium supplementation restores the concentrations of magnesium, potassium and sodium-potassium pumps in skeletal muscle of patients receiving diuretic treatment.

I Dørup1, K Skajaa, N K Thybo.   

Abstract

In 76 consecutive patients who had received diuretics for 1-17 years for arterial hypertension or congestive heart failure, muscle concentrations of magnesium, potassium, and sodium-potassium pumps were significantly reduced compared to 31 age- and sex-matched controls. Thirty-six patients with muscle magnesium and/or potassium below the control level received oral magnesium hydroxide supplement for 2-12 weeks (n = 20) or 26 weeks (n = 16). After short-term (2-12 weeks) magnesium supplementation muscle parameters were increased, but far from normalized. After magnesium supplementation for 26 weeks, the muscle concentrations of magnesium, potassium and sodium-potassium pumps were normalized in most cases. Oral magnesium supplementation may restore diuretic-induced disturbances in the concentrations of magnesium, potassium and sodium potassium pumps in skeletal muscle. A supplemental period of at least 6 months seems to be required before complete normalization can be expected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381850     DOI: 10.1111/j.1365-2796.1993.tb00663.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Use of diuretics in cardiovascular diseases: (1) heart failure.

Authors:  S U Shah; S Anjum; W A Littler
Journal:  Postgrad Med J       Date:  2004-04       Impact factor: 2.401

2.  Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes.

Authors:  C Wary; C Brillault-Salvat; G Bloch; A Leroy-Willig; D Roumenov; J M Grognet; J H Leclerc; P G Carlier
Journal:  Br J Clin Pharmacol       Date:  1999-11       Impact factor: 4.335

Review 3.  Drug-induced hypomagnesaemia : scope and management.

Authors:  Jacob Atsmon; Eran Dolev
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Magnesium in drinking water supplies and mortality from acute myocardial infarction in north west England.

Authors:  R Maheswaran; S Morris; S Falconer; A Grossinho; I Perry; J Wakefield; P Elliott
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

Review 5.  Human myocardial Na,K-ATPase concentration in heart failure.

Authors:  H Bundgaard; K Kjeldsen
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

Review 6.  Protective role of magnesium in cardiovascular diseases: a review.

Authors:  Sajal Chakraborti; Tapati Chakraborti; Malay Mandal; Amritlal Mandal; Sudip Das; Samarendranath Ghosh
Journal:  Mol Cell Biochem       Date:  2002-09       Impact factor: 3.396

Review 7.  Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.

Authors:  Emily S Mohn; Hua J Kern; Edward Saltzman; Susan H Mitmesser; Diane L McKay
Journal:  Pharmaceutics       Date:  2018-03-20       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.